• Lisa M Arkin, Leah Ansell, Alfred Rademaker, Megan L Curran, Michael L Miller, Annette Wagner, Brandi M Kenner-Bell, Sarah L Chamlin, Anthony J Mancini, Marisa Klein-Gitelman, and Amy S Paller.
• Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: Lisa.Arkin@gmail.com.
• J. Am. Acad. Dermatol. 2015 Apr 1; 72 (4): 628-33.

BackgroundPediatric discoid lupus erythematosus (DLE) is rare. The risk of progression to systemic lupus erythematosus (SLE) is uncertain.ObjectiveWe sought to determine the risk of progression of pediatric DLE to SLE and to characterize its phenotype.MethodsThis was a retrospective review of 40 patients with DLE.ResultsSix (15%) of 40 patients presented with DLE as a manifestation of concurrent SLE. Of the remaining 34, 9 (26%) eventually met SLE criteria and 15 (44%) developed laboratory abnormalities without meeting SLE criteria. Only 10 (29%) maintained skin-limited disease. The average age at progression to SLE was 11 years, with greatest risk in the first year after DLE diagnosis. Most (89%) patients with SLE met diagnostic criteria with mucocutaneous disease (discoid lesions, malar rash, oral and nasal ulcers, photosensitivity), positive antibodies, and/or cytopenia without developing end-organ damage over 5 years of median follow-up.LimitationsThe study was retrospective.ConclusionsIn pediatric patients, DLE carries a significant risk of progression to SLE but may predict a milder phenotype of systemic disease. All patients require careful monitoring for SLE, particularly within the first year of diagnosis.Copyright © 2014 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

40 keywords...

hide…